interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Sodium Thiosulfate

Generic competition · all medicines · read 12 November 2026

Is there a generic of Sodium Thiosulfate, and who makes it?

Sodium Thiosulfate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Sodium Thiosulfate2 dosage-form groups in the Orange Book
0generic makers listed
  1. Sodium Thiosulfate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Solution, Intravenous

Brand listed, no generic listed as marketed

Brand listed as marketed: Pedmark and Sodium Thiosulfate. No generic is listed as marketed.

201020152020202520302035204001brand 2012data datePatent 11753301 listed to expire 10 February 2030Patent 12304813 listed to expire 10 February 2030Patent 9345724 listed to expire 7 July 2030Patent 10479686 listed to expire 7 July 2030Patent 9585912 listed to expire 7 July 2030Patent 8496973 listed to expire 29 March 2031Patent 11998604 listed to expire 1 July 2039Patent 11992530 listed to expire 1 July 2039Patent 11964018 listed to expire 1 July 2039Patent 11617793 listed to expire 1 July 2039Patent 11510984 listed to expire 1 July 2039Patent 11291728 listed to expire 1 July 2039Exclusivity ODE-384 to 20 September 2029
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 20 September 2029Exclusivity ODE-384 Pedmark
  • 10 February 2030Patent 11753301 drug substance
  • 10 February 2030Patent 12304813 drug product
  • 7 July 2030Patent 9345724 drug substance
  • 7 July 2030Patent 10479686 drug product
  • 7 July 2030Patent 9585912 drug substance
  • 29 March 2031Patent 8496973 drug substance
  • 1 July 2039Patent 11998604
  • 1 July 2039Patent 11992530

4 more patents are listed.

Injectable, Injection

Nothing listed as marketed

Every brand product here is listed as discontinued. No generic is listed as marketed.

19901995200020052010201520202025203001brand 1992data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.